Cash on 31/03/2013 is probably around $72m, cash burn $10 per quarter without counting improvement sales from Bronchitol. It should last at least two years with further us$20m from Novaqeust.
ASIC shor reporting shows short positions increased further to 13.3m, unbelievable! Still record short position, that's why sp still hovering around 32c, might push down further unless we can hear some positive news.
9year low..., page-49
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
